All In Biotech

Drug Trial Radar · NCT05063149

Protecting Preterm Infants From Respiratory Tract Infections and Wheeze by Using Bacterial Lysates.

Protecting Late-moderate Preterm Infants From Respiratory Tract Infections and Wheeze in Their First Years of Life by Using Bacterial Lysates.

Last checked: Nov 19, 2026Latest source record: Sep 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 500 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

500

Planned (sponsor's estimate)

Start

Mar 18, 2022

Primary completion

Dec 2029

Study completion Dec 2030

Sponsor

Lead sponsor
Franciscus GasthuisAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Leiden University Medical Center; Maastricht University Medical Center; Erasmus Medical Center
First posted
Sep 30, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 6 weeks, up to 10 weeks
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to reduce respiratory tract infections and wheezing in moderate-late preterms in the first years of life by bacterial lysate administration. Next to determine the correlation of biological markers with respiratory symptoms, immune protection and treatment effect.

Conditions

  • Wheezing
  • LRTI
  • Premature

Interventions

  • Broncho-VaxomDrug

    Broncho-Vaxom is a bacterial extract comprising lyophilised fractions of 21 different inactivated bacterial strains, which are frequently causing RTI.

  • PlaceboOther

    Placebo powder from a capsule will be given, which will be indistinguishable from the active study drug.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Total number of physician diagnosed lower RTI and wheezing episodes in the first year of lifeTime frame: In the first year of life.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Franciscus Gasthuis & Vlietland

    Rotterdam, South Holland, Netherlands · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.